InnoFluidics

InnoFluidics aims for decreasing the cancer burden by providing innovative technologies. InnoFluidics' rare cell analysis platform will purify and collect tumor cells that are circulating in blood with a simple blood test. As these cells contain all the information related to the disease, our proprietary technology will guide specialists in their clinical decision making and be used as a tool for drug development. We have proved the validity of our approach with model samples and now working for building a prototype to be tested in clinics.